Task: Answer the multiple choice question.
Question: Which compound exhibits a 10.121\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) O=C(CS(=O)(=O)c1cn(CC(=O)N2CCOCC2)c2ccccc12)Nc1ccccc1
b.) COc1ccc(C(=O)Oc2ccc3oc(=O)sc3c2)cc1
c.) CS(=O)(=O)c1ccc(Cl)c(C(=O)NC2CCSc3ccccc32)c1
d.) COc1ccc(Cc2nnc(SCC(=O)Nc3ccccc3)[nH]c2=O)cc1
e.) O=C(NC1CCCCCC1)C1CCN(S(=O)(=O)N2CCC3(CC2)OCCO3)CC1
Answer: d. COc1ccc(Cc2nnc(SCC(=O)Nc3ccccc3)[nH]c2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cc2nnc(SCC(=O)Nc3ccccc3)[nH]c2=O)cc1
COc1ccc(Cc2nnc(SCC(=O)Nc3ccccc3)[nH]c2=O)cc1
2-[[6-[(4-methoxyphenyl)methyl]-5-oxo-4H-1,2,4-triazin-3-yl]sulfanyl]-N-phenylacetamide